Page last updated: 2024-10-17

aminocaproic acid and Anemia, Hemolytic

aminocaproic acid has been researched along with Anemia, Hemolytic in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HASEGAWA, Y1
TSUKADA, R1
Ortel, TL1
Onorato, JJ1
Bedrosian, CL1
Kaufman, RE1

Other Studies

2 other studies available for aminocaproic acid and Anemia, Hemolytic

ArticleYear
[RECENT INFORMATION ON THE THERAPY OF BLOOD DISEASES].
    [Chiryo] [Therapy], 1964, Volume: 46

    Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Aminocaproates; Aminocaproic Acid; Anabolic Age

1964
Antifibrinolytic therapy in the management of the Kasabach Merritt syndrome.
    American journal of hematology, 1988, Volume: 29, Issue:1

    Topics: Adult; Aminocaproic Acid; Anemia, Hemolytic; Antifibrinolytic Agents; Arm; Blood Cell Count; Blood T

1988